Owing to improved technology and the decline in peritonitis rates, ultrafiltration failure (UFF)/membrane failure has now become one of the major factors leading to technique failure in PD patients. Typically,…
EPIDEMIOLOGY OF POISONING Although poisoning has been reported to health care institutions for a long time, its incidence is clearly underestimated. The incidence of poisoning continues to increase largely due…
TECHNICAL ASPECTS OF RENAL REPLACEMENT THERAPY IN THE INTENSIVE CARE UNIT This section of the chapter discusses different modalities of RRT in the ICU and review through the calculations for…
As kidney disease progresses, renal regulation of acid balance is lost and metabolic acidosis ensues, due primarily to impaired acid excretion. Initiation of renal replacement therapy addresses this problem not…
MODALITIES OF CONTINUOUS RENAL REPLACEMENT THERAPY—TECHNICAL CONSIDERATIONS Terminology Continuous therapies encompass a variety of modalities that vary in the terminology. Recently, an international group of experts has developed the Acute…
DEFINITION OF OXIDANT STRESS Oxidative stress is a pathologic state in which reactive oxygen intermediates (ROI) or reactive oxygen species (ROS) can cause oxidation of cellular and matrix macromolecules including…
Some have suggested that this increased rate of mortality in dialysis patients is due to inadequacies in the prescribed dose of dialysis (4,5). However, it is acknowledged that there is…
LIFE PLANNING A patient facing ESKD must understand that no matter how successful his or her therapy (dialysis and/or transplantation), life span is less than if ESKD were not present….
BRIEF HISTORY OF VASCULAR ACCESS The history of vascular access for hemodialysis is closely tied to the history of dialysis. In 1924, Georg Haas in Giessen, Germany, performed the first…
BIOCHEMICAL ABNORMALITIES IN PATIENTS WITH CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER The first component of CKD-MBD is abnormal mineral metabolism including that of serum calcium, phosphate, PTH, vitamin D, and…
